The Nebulizer Market was valued at USD 979.4 million in 2019 and is expected to grow with a CAGR of 6.8 % during the forecast period, 2021–2029.

Nebulizer Market 2021

Nebulizers change the liquid dosage to mist for easy inhalation. In other words, the process of converting a bulk liquid pneumatically into small aerosol droplets for inhalation purposes is called nebulization.  Nebulizers are commonly used as drug delivery devices for bronchodilators, chronic respiratory diseases, cystic fibrosis, asthma, and chronic obstructive pulmonary disorder (COPD). As per the World Health Organization (WHO), around 3 million deaths are reported each year due to COPDs, which is about 6% of all deaths across the world.

Get a  Sample copy of this report :
https://straitsresearch.com/report/nebulizer-market/request-sample

The Major Manufacturers Covered in this Report:
Omron, Koninklijke Philips, PARI Respiratory Equipment, Allied Healthcare Products Inc., Agilent Technologies, Inc., CareFusion Corporation, GF Health Products, Inc., DeVilbiss Healthcare, Aerogen and more...

Years that have been considered for the study of this report are as follows:

History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2021 to 2029

Market Segmentation:

By Type

Jet nebulizers
Mesh nebulizers
Ultrasonic nebulizers

By End-User

Hospitals and clinics
Emergency centers
Home healthcare

Regional Segmentation:

North America (The US, Canada, and Mexico)
Europe (Germany, France, the UK, and Rest of the World)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America.)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)

Impact of COVID 19

Globally, the rising prevalence of several respiratory diseases such as COVID 19, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS) prompt the dire need for effective nebulizers for quick delivery of sufficient drug with minimal wastage. The coronavirus primarily attacks the human respiratory system, further rising the need for nebulization therapy during the course of the treatment. Currently, the market is facing a shortage of nebulizers as companies and wholesalers are running out of stock due to disruption in the supply chain, further hampering the market growth.

The analysis objectives of the report are:

To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry specific challenge and risks).
To know the Nebulizer Market by pinpointing its many sub segments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of the Nebulizer Market sub-markets, depending on key regions (various vital states).
To analyze the Global Nebulizer Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Global Nebulizer Market size (volume and value) form the company, essential regions/countries, products and applications, background information and also predictions.
Primary worldwide Global Nebulizer Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans for the next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

Explore Full Report with Detailed TOC, Charts, Tables and Figures@
https://straitsresearch.com/report//nebulizer-market/

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

This release was published on openPR.